SOTERA HEALTH COMPANY

(SHC)
  Report
Delayed Nasdaq  -  04:00 2022-08-18 pm EDT
19.85 USD   +0.76%
08/05RBC Cuts Price Target on Sotera Health to $25 From $31, Maintains Outperform Rating
MT
08/04SOTERA HEALTH CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
08/04Sotera Health Company Q2 Adjusted Earnings, Revenue Rise; Company Narrows 2022 Guidance
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sotera Health Company Reports Earnings Results for the First Quarter Ended March 31, 2022

05/05/2022 | 07:00am EDT

Sotera Health Company reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was USD 236.75 million compared to USD 212.15 million a year ago. Net income was USD 30.64 million compared to USD 10.84 million a year ago. Basic earnings per share from continuing operations was USD 0.11 compared to USD 0.04 a year ago. Diluted earnings per share from continuing operations was USD 0.11 compared to USD 0.04 a year ago.


© S&P Capital IQ 2022
All news about SOTERA HEALTH COMPANY
08/05RBC Cuts Price Target on Sotera Health to $25 From $31, Maintains Outperform Rating
MT
08/04SOTERA HEALTH CO Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/04Sotera Health Company Q2 Adjusted Earnings, Revenue Rise; Company Narrows 2022 Guidance
MT
08/04TRANSCRIPT : Sotera Health Company, Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04SOTERA HEALTH : Reports Second-Quarter and First-Half 2022 Results - Form 8-K
PU
08/04Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC Posts Q2 Revenue $266.6M
MT
08/04Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC Posts Q2 EPS $0.27
MT
08/04Sotera Health Reports Second-Quarter and First-Half 2022 Results
GL
08/04Sotera Health Reports Second-Quarter and First-Half 2022 Results
AQ
08/04Sotera Health Company Revises Earnings Guidance for the Full Year 2022
CI
More news
Analyst Recommendations on SOTERA HEALTH COMPANY
More recommendations
Financials (USD)
Sales 2022 1 015 M - -
Net income 2022 134 M - -
Net Debt 2022 1 416 M - -
P/E ratio 2022 41,5x
Yield 2022 -
Capitalization 5 616 M 5 616 M -
EV / Sales 2022 6,93x
EV / Sales 2023 6,15x
Nbr of Employees 3 000
Free-Float 96,0%
Chart SOTERA HEALTH COMPANY
Duration : Period :
Sotera Health Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SOTERA HEALTH COMPANY
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 19,85 $
Average target price 24,57 $
Spread / Average Target 23,8%
EPS Revisions
Managers and Directors
Michael B. Petras Chief Executive Officer
Michael Francis Biehl Chief Financial Officer
Robert G. Hauzie Chief Information Officer
Sean Laurence Cunningham Independent Director
Dave Anthony Donnini Independent Director